NPPA issued a notification regarding the fixation of the retail price of Sitagliptin phosphate monohydrate IP

May 23, 2024 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on May 22, 2024, issued a notification regarding the fixation of the retail price of Sitagliptin phosphate monohydrate IP.

The following has been stated: -

• For each film-coated bilayered tablet containing Sitagliptin phosphate monohydrate IP eq. to Sitagliptin 100 mg + Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg + Metformin Hydrochloride IP (As sustained release form) 500 mg for M/s Akums Drugs & Pharmaceuticals Ltd (Manufacturer) and M/s Glenmark Pharmaceuticals Ltd. (Marketer) the retail price is 14.00 (Rs.)

[Notification No. 19(3976) /2024/DP/NPPA/Div.III/8136/2024]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT